Done sou Salè H1B

Akèy › Metiyè › Biochemists and Biophysicists › San Francisco, CA

Biochemists and Biophysicists nan San Francisco, CA: Salè H-1B

693 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan San Francisco, CA. Salè baz medyàn ofri $79,569; mwatye mitan $71,952–$91,300.

Demann (LCA)693
Salè medyan ofri$79,569
Mwatye salè yo$71,952–$91,300
10yèm–90yèm pousantaj$65,657–$114,200

Pa nivo salè

Nivo revniSalè medyan
Nivo I (antre)$107,833
Nivo II (kalifye)$115,000
Nivo III (eksperyans)$122,900
Nivo IV (plen kompetans)$163,500

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Anplwayè yo

AnplwayèLCASalè medyan
University of California, San Francisco613$77,327
Nurix Therapeutics, Inc.20$115,000
Vir Biotechnology, Inc.14$128,230
CZ Biohub SF, LLC6$120,800
The J. David Gladstone Institutes4$79,852
Howard Hughes Medical Institute4$72,100
Vitalant4$85,255
MRL San Francisco, LLC2$165,875
Wild Type, Inc.2$128,500
GigaMune, Inc2$130,500
Topaz Therapeutics, Inc.2$112,882
Goodwin Procter LLP2$165,000
Thermo Fisher Scientific Inc.1$111,072
FibroGen, Inc.1$111,072
Open Philanthropy Project1$124,921
Iaterion, Inc.1$105,000
THG Beauty USA LLC1$162,000
Vitalant Research Institute1$88,060
Gilead Sciences, Inc.1$88,670
Weatherwax Biotechnologies Corporation1$120,000
Utter Therapeutics Inc.1$140,000
Coterie Baby, Inc.1$175,000
Vivid BioInnovations PBC1—
Northern California Institute for Research and Education1$70,304
Episteme, Inc.1$90,000
Qymune Inc1$100,000
Genentech, Inc.1$101,400
Alkali Labs, Inc.1$155,000
Novo Holdings (US) Inc.1$164,000
Lume Health Technologies Inc.1$120,000

Tit travay

Pwonse H-1B nan San Francisco, CA →

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).